Dana Aftab - 05 Jan 2023 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Role
CSO/EVP Disc & Trans Research
Signature
/s/ Nina Ayer, Attorney in Fact
Issuer symbol
EXEL
Transactions as of
05 Jan 2023
Net transactions value
$0
Form type
4
Filing time
09 Jan 2023, 18:58:58 UTC
Previous filing
23 Dec 2022
Next filing
17 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXEL Common Stock Award $0 +100,000 +40% $0.000000 353,001 05 Jan 2023 Direct F1, F2, F3
holding EXEL Common Stock 5,835 05 Jan 2023 By 401(k) F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock.
F2 The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Subject to the terms of the restricted stock unit award, the restricted stock units will vest as follows: 25,000 on February 15, 2024 and, thereafter, 25,000 on each of February 15, 2025, 2026 and 2027.
F3 Includes 213,838 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
F4 Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of January 5, 2023.